1 unchanged sentence
Market for our Common Stock and Warrants
−Removed: Our Class A Common Stock is traded on the Nasdaq Stock Market under the ticker symbol “LIFW.”
+Added: Our Class A Common Stock is traded on the Nasdaq Stock Market under the ticker symbol “MSPR.”
Our Class V Common stock is not listed on any stock exchange nor traded on any public market.
−Removed: Our Public Warrants are traded on the Nasdaq Stock Market under the ticker symbol “LIFWZ.”
−Removed: Our New Warrants are traded on the Nasdaq Stock Market under the ticker symbol “LIFWW.”
+Added: Our Public Warrants are traded on the Nasdaq Stock Market under the ticker symbol “MSPRZ.”
+Added: Our New Warrants are traded on the Nasdaq Stock Market under the ticker symbol “MSPRW.”
Record Holders
7 unchanged sentences
Unregistered Sales of Equity Securities
−Removed: Palantir Technologies, Inc.
During the fiscal year ending December 31, 2024, the Company issued 305,133 unregistered shares of Class A Common Stock to Palantir, in exchange for services provided in reliance on Section 4(a)(2) of the U.S.
Securities Act of 1933.
−Removed: Pursuant to a purchase agreement dated October 25, 2023, and as disclosed on his Form 4 dated October 26, 2023, on October 26, 2023, the Company issued 467,290 unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr.
−Removed: In addition, pursuant to a purchase agreement dated March 4, 2024, and as disclosed on his Form 4 dated March 4, 2024, the Company issued 438,596 unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr.
−Removed: Pursuant to a purchase agreement dated September 25, 2023, and as disclosed on his Form 4 dated October 2, 2023, on September 29, 2023, the Company issued 274,726 unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr.
−Removed: Cano Health, LLC
−Removed: Pursuant to the Second Amendment to Amended and Restated Claims Recovery and Assignment Agreement and the First Amendment to the Purchase Agreement by and among the Company and Cano, on July 7, 2023, the Company issued 7,960,001 unregistered shares of Class A Common Stock to Cano.
−Removed: Virage Warrants
−Removed: Pursuant to the MTA Amendment, on December 22, 2023, the Company agreed to issue to Virage an initial warrant on January 1, 2024, entitling Virage to purchase 28,298,329 shares of Class A Common Stock, with an exercise price of $0.0001 per share and an expiration date of January 1, 2026.
−Removed: On April 1, 2024, the Company issued Virage:
−Removed: (i) a warrant entitling Virage to purchase 8,263,494 shares of Class A Common Stock, with an exercise price of $0.0001 per share and an expiration date of February 1, 2026;
−Removed: (ii) a warrant entitling Virage to purchase 11,955,994 shares of Class A Common Stock, with an exercise price of $0.0001 per share and an expiration date of March 1, 2026;
−Removed: and (iii) a warrant entitling Virage to purchase 13,556,181 shares of Class A Common Stock, with an exercise price of $0.0001 per share and an expiration date of April 1, 2026.
+Added: Pursuant to a purchase agreement dated March 4, 2024, and as disclosed on his Form 4 dated March 4, 2024, the Company issued 17,544 unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr.
+Added: In partial satisfaction of amounts owed by the Company pursuant to that certain Services Agreement dated May 20, 2022 between Virage and the Company, on May 23, 2024 the Company issued, among other things, 20,000 shares of the Company’s Class A Common Stock to VRP.
+Added: During 2024, the Company sold 1,108,071 shares of Class A Common Stock to Yorkville pursuant to investor and/or advance notices delivered under the Yorkville SEPA at prices between $1.78 and $21.09 per share.
+Added: The proceeds therefrom were used to:
+Added: (i) reduce amounts owed under Yorkville Note #1 by $2.8 million and $0.2 million of principal and interest, respectively, for fiscal year 2024, (ii) $0.5 million to fund operations of the Company, and (iii) $2.6 million of payment to reduce amounts owed under the Nomura Note for fiscal year 2024.
Issuer Purchases of Equity Securities
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.